Adenosine A(1) Receptor Agonists as Clinically Viable Agents for Treatment of Ischemic Brain Disorders

Podobne zapisy

• Protection against ischemic damage by adenosine amine congener, a potent and selective adenosine A(1) receptor agonist
  od: Von Lubitz, Dag K.J.E., i wsp.
  Wydane: (1999)
• Chronic administration of adenosine A(3) receptor agonist and cerebral ischemia: neuronal and glial effects
  od: Von Lubitz, Dag K.J.E., i wsp.
  Wydane: (1999)
• Reduction of postischemic brain damage and memory deficits following treatment with the selective adenosine A(1) receptor agonist
  od: Von Lubitz, Dag K.J.E., i wsp.
  Wydane: (1996)
• Cerebral ischemia in gerbils: effects of acute and chronic treatment with adenosine A(2A) receptor agonist and antagonist
  od: Von Lubitz, Dag K.J.E., i wsp.
  Wydane: (1995)
• Effects of chronic administration of adenosine A(1) receptor agonist and antagonist on spatial learning and memory
  od: Von Lubitz, Dag K.J.E., i wsp.
  Wydane: (1993)